2020 was a challenging year in more ways than one, and many agencies acknowledged those hardships in holiday cards and video messages. One agency took a slightly different approach: CDM New York created their own eBay page to auction off “The Year 2020” at a starting price of a single penny.

REGENXBIO Inc. provided an update on the RGX-314 programs, including the announcement that the pivotal program for RGX-314 for the treatment of wet age-related macular degeneration (wet AMD) is active.

Apex Innovative Sciences and the company’s affiliates announced their participation in three Covid-19 vaccine studies.

The COVID-19 Webinar, “A Pandemic of Legal Liability For Employers and Businesses,” will be held Thursday, January 21, 2021.

Inovio Pharmaceuticals Inc. expects to start a late-stage U.S. study of the company’s experimental Covid-19 vaccine candidate in the second quarter of 2021, the drug developer’s chief executive officer said.

The Centers for Disease Control and Prevention administered 4,563,260 first doses of Covid-19 vaccines in the United States as of the morning of Jan. 4 and distributed 15,418,500 doses.

Calithera Biosciences reported that the company’s CANTATA clinical trial of telaglenastat in patients with advanced or metastatic renal cell carcinoma (RCC) failed to hit the primary endpoint.

Britain became the first country to vaccinate its population with Oxford University and AstraZeneca’s Covid-19 shot on Jan. 4, but Prime Minister Boris Johnson was set to tighten restrictions in England in a bid to slow the spread of cases.

At the start of 2021, 70 companies raised the price of hundreds of prescription drugs by an average of 3.3%.

The Transportation Security Administration (TSA) screened 500 million fewer people at U.S. airport checkpoints in 2020, down 61% versus 2019, as air travel slowed sharply during the coronavirus pandemic.